Tags : Ieso

PharmaShots Weekly Snapshot (September 23– 27, 2019)

Vartika Singh September 30, 2019

1. Incyte Reports Updated Results of Pemigatinib in P-II FIGHT-202 Trial for Patients with Previously Treated Advanced Cholangiocarcinoma Published: Sept 27, 2019 | Tags: Incyte, Reports, Updated, Results, Pemigatinib, P-II, FIGHT-202 […]readmore

DigiHealth

Ieso Launches Eight Billion Minds Digital Initiative Addressing Unmet Mental

Vartika Singh September 27, 2019

Shots: Ieso Digital Health has launched Eight Billion Minds, a digital therapeutics program focusing on addressing the global and regional shortages of mental health practitioners Eight Billion Minds is built […]readmore

Tags : Ieso

PharmaShots Weekly Snapshot (September 23– 27, 2019)

Ieso Launches Eight Billion Minds Digital Initiative Addressing Unmet Mental

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Ieso

﻿PharmaShots Weekly Snapshot (September 23– 27, 2019)

Ieso Launches Eight Billion Minds Digital Initiative Addressing Unmet Mental

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company

PharmaShots Weekly Snapshot (September 23– 27, 2019)